September 11, 2024 Top Stocks For Smart Investment Choices
September 8, 2024 S&P 500 In Freefall: Is This The End Of The Bull Market?
September 6, 2024 Jobs Report Spotlight As Fed Weighs Rate Cut Decision
August 26, 2024 NVDA Earnings Report Insights
Amazon: Oracle Partnership Highlights Margin Expansion Potential
Nvidia: Why You Should Buy Before It Hits $145
Apple: Enough To Turn The Odds In Its Favor – Still Buy
AMD Is Coming For Nvidia’s AI Lead
Nvidia: Goldman Sachs’ Hilarious Downside Case
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Amgen (AMGN) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: September 13, 2024 (13:54)
Sector: HealthcareThe share price of Amgen Inc. (AMGN) now
Are you interested in Amgen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Amgen stock price in 2024, 2025, 2026, 2027, 2028. How much will one Amgen share be worth in 2024 - 2028?
When should I take profit in Amgen stock? When should I record a loss on Amgen stock? What are analysts' forecasts for Amgen stock? What is the future of Amgen stock? We forecast Amgen stock performance using neural networks based on historical data on Amgen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Amgen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Amgen shares. This happens once a day.
Historical and forecast chart of Amgen stock
The chart below shows the historical price of Amgen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Amgen stock price can be found in the table below.
Long-term forecasts by years.
AMGen is an American biopharmaceutical company and the largest transnational independent biotechnology firm in the world. AMGen is engaged in research in the field of biology, opening up opportunities for patients with serious diseases such as cancer, bone damage, various kidney diseases, autoimmune diseases (in particular rheumatoid arthritis) and other diseases. The company uses progressive methods of gene engineering, which makes it possible to identify the complex pathogenesis of diseases, to comprehend the basics of human biology.
AMGen was founded in 1980, co-founder George B. Ratmann became the first CEO of the company, after several changes of leadership in May 2012, Robert A. Bradway, who has a bachelor’s degree in biology and a master’s degree from Harvard University, took the position. The company has had at least five major corporate acquisitions.
Amgen daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Sep 15 | 334.35 | 329.47 | 337.16 | 2.33 |
| Sep 16 | 335.75 | 330.45 | 337.57 | 2.15 |
| Sep 17 | 334.14 | 329.06 | 336.21 | 2.17 |
| Sep 18 | 337.35 | 332.76 | 338.70 | 1.78 |
| Sep 19 | 338.36 | 336.06 | 342.96 | 2.05 |
| Sep 20 | 339.85 | 338.22 | 341.96 | 1.11 |
| Sep 21 | 337.81 | 332.61 | 343.01 | 3.13 |
| Sep 22 | 337.47 | 333.63 | 341.25 | 2.29 |
| Sep 23 | 333.70 | 329.89 | 338.70 | 2.67 |
| Sep 24 | 332.23 | 328.04 | 336.28 | 2.51 |
| Sep 25 | 332.89 | 331.09 | 334.42 | 1.01 |
| Sep 26 | 332.03 | 328.84 | 334.08 | 1.60 |
| Sep 27 | 330.10 | 327.86 | 334.72 | 2.09 |
| Sep 28 | 335.51 | 332.36 | 338.00 | 1.70 |
| Sep 29 | 333.17 | 330.23 | 336.76 | 1.98 |
| Sep 30 | 336.03 | 334.55 | 338.25 | 1.11 |
| Oct 01 | 335.69 | 332.40 | 338.38 | 1.80 |
| Oct 02 | 332.40 | 329.08 | 337.59 | 2.59 |
| Oct 03 | 329.48 | 327.24 | 331.39 | 1.27 |
| Oct 04 | 327.24 | 324.88 | 329.92 | 1.55 |
| Oct 05 | 325.60 | 321.76 | 329.18 | 2.31 |
| Oct 06 | 326.84 | 324.55 | 328.34 | 1.17 |
| Oct 07 | 329.98 | 328.33 | 334.40 | 1.85 |
| Oct 08 | 331.10 | 329.51 | 336.13 | 2.01 |
| Oct 09 | 330.70 | 325.41 | 333.15 | 2.38 |
| Oct 10 | 331.76 | 329.50 | 335.61 | 1.85 |
| Oct 11 | 330.37 | 327.26 | 334.86 | 2.32 |
| Oct 12 | 325.21 | 321.90 | 326.97 | 1.58 |
| Oct 13 | 319.75 | 317.32 | 322.37 | 1.59 |
| Oct 14 | 321.54 | 318.07 | 324.50 | 2.02 |
Amgen Daily Price Targets
Amgen Stock Forecast 09-15-2024.
Forecast target price for 09-15-2024: $334.35.
Positive dynamics for Amgen shares will prevail with possible volatility of 2.281%.
Pessimistic target level: 329.47
Optimistic target level: 337.16
Amgen Stock Forecast 09-16-2024.
Forecast target price for 09-16-2024: $335.75.
Positive dynamics for Amgen shares will prevail with possible volatility of 2.109%.
Pessimistic target level: 330.45
Optimistic target level: 337.57
Amgen Stock Forecast 09-17-2024.
Forecast target price for 09-17-2024: $334.14.
Negative dynamics for Amgen shares will prevail with possible volatility of 2.127%.
Pessimistic target level: 329.06
Optimistic target level: 336.21
Amgen Stock Forecast 09-18-2024.
Forecast target price for 09-18-2024: $337.35.
Positive dynamics for Amgen shares will prevail with possible volatility of 1.753%.
Pessimistic target level: 332.76
Optimistic target level: 338.70
Amgen Stock Forecast 09-19-2024.
Forecast target price for 09-19-2024: $338.36.
Positive dynamics for Amgen shares will prevail with possible volatility of 2.012%.
Pessimistic target level: 336.06
Optimistic target level: 342.96
Amgen Stock Forecast 09-20-2024.
Forecast target price for 09-20-2024: $339.85.
Positive dynamics for Amgen shares will prevail with possible volatility of 1.093%.
Pessimistic target level: 338.22
Optimistic target level: 341.96
AMGN (AMGN) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct. | 321.74 | 295.10 | 346.45 | 14.82 |
| Nov. | 329.08 | 297.88 | 341.32 | 12.73 |
| Dec. | 330.66 | 306.06 | 348.51 | 12.18 |
Amgen forecast for this year
Amgen Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $321.742. Pessimistic: $295.10. Optimistic: $346.45
Amgen Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $329.078. Pessimistic: $297.88. Optimistic: $341.32
Amgen Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $330.658. Pessimistic: $306.06. Optimistic: $348.51
Amgen (AMGN) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 292.17 | 284.11 | 319.52 | 11.08 |
| Feb | 303.74 | 282.60 | 332.17 | 14.92 |
| Mar | 322.33 | 304.54 | 348.24 | 12.55 |
| Apr | 316.53 | 302.09 | 327.54 | 7.77 |
| May | 315.39 | 303.28 | 332.42 | 8.77 |
| Jun | 308.57 | 287.47 | 333.75 | 13.87 |
| Jul | 280.43 | 271.68 | 302.31 | 10.13 |
| Aug | 289.52 | 262.77 | 316.27 | 16.92 |
| Sep | 270.06 | 247.05 | 290.80 | 15.04 |
| Oct | 256.45 | 249.37 | 270.92 | 7.95 |
| Nov | 245.07 | 230.66 | 265.95 | 13.27 |
| Dec | 255.95 | 248.58 | 264.24 | 5.93 |
Amgen (AMGN) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 284.20 | 259.31 | 295.80 | 12.34 |
| Feb | 300.91 | 285.03 | 320.77 | 11.14 |
| Mar | 321.86 | 298.30 | 346.19 | 13.83 |
| Apr | 332.29 | 302.78 | 360.60 | 16.03 |
| May | 305.57 | 281.00 | 321.70 | 12.65 |
| Jun | 315.10 | 296.58 | 343.08 | 13.56 |
| Jul | 309.81 | 300.89 | 336.95 | 10.70 |
| Aug | 274.49 | 265.93 | 283.39 | 6.16 |
| Sep | 259.34 | 248.45 | 267.12 | 6.99 |
| Oct | 249.07 | 234.72 | 258.63 | 9.25 |
| Nov | 252.06 | 240.26 | 260.53 | 7.78 |
| Dec | 271.11 | 255.50 | 296.17 | 13.73 |
Amgen information and performance
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US
Market capitalization of the Amgen Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of AMGN shares in the company outstanding by the market price of one share.
EBITDA of Amgen is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Amgen (AMGN) stock dividend
Amgen last paid dividends on 08/16/2024. The next scheduled payment will be on 09/06/2024. The amount of dividends is $8.76 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
